[ad_1] The CDK4/6 inhibitors market is expected to grow significantly in the coming years. This is mainly due to the increasing incidence of HR+/HER2 breast cancer, the type for which CDK4/6 inhibitors are majorly prescribed. CDK4/6 […]
Tag: DelveInsight Business Research
The Positive Topline Results From Phase III Study of UCB/Biogen’s Dapirolizumab Pegol Brings a Ray of Hope in Systemic Lupus Erythematosus Therapeutic Space
[ad_1] UCB and Biogen reported encouraging topline findings from the Phase III PHOENYCS GO trial, which assessed dapirolizumab pegol, a novel Fc-free anti-CD40L drug candidate, in individuals with moderate-to-severe SLE. The promising outcomes with dapirolizumab […]
Global Telemedicine Market to Cross ~USD 14 Billion by 2030
[ad_1] The growing number of medical conditions that require frequent check-ups is likely boosting the telemedicine market. Regular therapy sessions, psychiatric consultations, children’s frequent health checks for vaccinations and growth monitoring, and ongoing evaluation and […]
Ipsen’s IQIRVO Approval Has Intensified the Primary Biliary Cholangitis Market Space
[ad_1] The European Commission has granted conditional approval for Ipsen’s IQIRVO (elafibranor) for the treatment of primary biliary cholangitis in adults, marking the first new therapy for this condition to be approved in the EU […]
Global Hormone Replacement Therapy Market to Grow Substantially at a CAGR of ~6% by 2030
[ad_1] The hormone replacement therapy market is witnessing substantial growth due to the rising occurrence of hormonal and targeted conditions such as menopause and osteoporosis, coupled with the growing elderly population, which is fueling demand […]
